Meixner, E.; Wermes, L.; Hoeltgen, L.; von Diest, L.A.; Sandrini, E.; Harrabi, S.; Seidensaal, K.; Hoegen-Saßmannshausen, P.; Vinsensia, M.; König, L.;
et al. Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical Cancer. Cancers 2024, 16, 3986.
https://doi.org/10.3390/cancers16233986
AMA Style
Meixner E, Wermes L, Hoeltgen L, von Diest LA, Sandrini E, Harrabi S, Seidensaal K, Hoegen-Saßmannshausen P, Vinsensia M, König L,
et al. Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical Cancer. Cancers. 2024; 16(23):3986.
https://doi.org/10.3390/cancers16233986
Chicago/Turabian Style
Meixner, Eva, Laura Wermes, Line Hoeltgen, Lisa Antonia von Diest, Elisabetta Sandrini, Semi Harrabi, Katharina Seidensaal, Philipp Hoegen-Saßmannshausen, Maria Vinsensia, Laila König,
and et al. 2024. "Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical Cancer" Cancers 16, no. 23: 3986.
https://doi.org/10.3390/cancers16233986
APA Style
Meixner, E., Wermes, L., Hoeltgen, L., von Diest, L. A., Sandrini, E., Harrabi, S., Seidensaal, K., Hoegen-Saßmannshausen, P., Vinsensia, M., König, L., Arians, N., Debus, J., & Hörner-Rieber, J.
(2024). Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical Cancer. Cancers, 16(23), 3986.
https://doi.org/10.3390/cancers16233986
